Nov 11, 2010, 06.38 PM IST
Samrat Pharmachem reports Rs 12.44 crore turnover for quarter ended Sep 2010
Samrat Pharmachem has reported a sales turnover of Rs 12.44 crore and a net profit of Rs 0.31 crore for the quarter ended Sep 2010
Like this story, share it with millions of investors on M3
Samrat Pharmachem reports Rs 12.44 crore turnover for quarter ended Sep 2010
Samrat Pharmachem has reported a sales turnover of Rs 12.44 crore and a net profit of Rs 0.31 crore for the quarter ended Sep 2010
Like this story, share it with millions of investors on M3
Samrat Pharmachem reports Rs 12.44 crore turnover for quarter ended Sep 2010
Samrat Pharmachem has reported a sales turnover of Rs 12.44 crore and a net profit of Rs 0.31 crore for the quarter ended Sep 2010
Share .
Email .
Print .
A+A-
Samrat Pharmachem has reported a sales turnover of Rs 12.44 crore and a net profit of Rs 0.31 crore for the quarter ended Sep 2010.
| For the quarter ended Sep 2009 the sales turnover was Rs 11.81 crore and net profit was Rs 0.25 crore.
|
|
| | Quarterly Results of Samrat Pharmachem | -------- in Rs. Cr. -------- |
|
| Sep '09 | | | Jun '10 | Sep '10 | | Sales Turnover | 11.81 | | | 10.77 | 12.44 | | Other Income | -- | | | -- | -- | | Total Income | 11.81 | | | 10.77 | 12.44 | | Total Expenses | 11.35 | | | 10.28 | 11.96 | | Operating Profit | 0.46 | | | 0.49 | 0.48 | | Profit On Sale Of Assets | -- | | | -- | -- | | Profit On Sale Of Investments | -- | | | -- | -- | | Gain/Loss On Foreign Exchange | -- | | | -- | -- | | VRS Adjustment | -- | | | -- | -- | | Other Extraordinary Income/Expenses | -- | | | -- | -- | | Total Extraordinary Income/Expenses | -0.10 | | | -- | -- | | Tax On Extraordinary Items | -- | | | -- | -- | | Net Extra Ordinary Income/Expenses | -- | | | -- | -- | | Gross Profit | 0.46 | | | 0.49 | 0.48 | | Interest | 0.08 | | | -0.01 | 0.04 | | PBDT | 0.29 | | | 0.50 | 0.44 | | Depreciation | 0.04 | | | 0.04 | 0.04 | | Depreciation On Revaluation Of Assets | -- | | | -- | -- | | PBT | 0.25 | | | 0.46 | 0.40 | | Tax | -- | | | 0.10 | 0.09 | | Net Profit | 0.25 | | | 0.36 | 0.31 | | Prior Years Income/Expenses | -- | | | -- | -- | | Depreciation for Previous Years Written Back/ Provided | -- | | | -- | -- | | Dividend | -- | | | -- | -- | | Dividend Tax | -- | | | -- | -- | | Dividend (%) | -- | | | -- | -- | | Earnings Per Share | 0.82 | | | 1.16 | 1.00 | | Book Value | -- | | | -- | -- | | Equity | 3.09 | | | 3.09 | 3.09 | | Reserves | -- | | | -- | -- | | Face Value | 10.00 | | | 10.00 | 10.00 | | Source : Religare Technova |
|
